Oruka Therapeutics (ORKA) Depreciation and Depletion (2024 - 2026)
Oruka Therapeutics' quarterly Depreciation and Depletion came in at $43000.0 in Q1 2026, up 168.75% year-on-year from $16000.0 in Q1 2025, and up 53.57% quarter-over-quarter from $28000.0 in Q4 2025.
Oruka Therapeutics has reported Depreciation and Depletion for 3 years, with the latest figure at $43000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 168.75% year-over-year to $43000.0; the trailing twelve-month figure through Mar 2026 stood at $110000.0 (changed N/A YoY), and the FY2025 full-year result was $83000.0, up 207.41% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $43000.0, up from $28000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $43000.0 in Q1 2026, with the low at $16000.0 in Q4 2024.
- Average Depreciation and Depletion over 3 years is $23666.7, with a median of $19500.0 recorded in 2025.
- Year-over-year, Depreciation and Depletion soared 75.0% in 2025 and surged 168.75% in 2026.
- Tracing ORKA's Depreciation and Depletion over 3 years: stood at $16000.0 in 2024, then soared by 75.0% to $28000.0 in 2025, then surged by 53.57% to $43000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $43000.0 (Q1 2026), $28000.0 (Q4 2025), and $20000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 43,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,000.00 |
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |